Document is current
Any future updates will be listed below
-
Authors
Shallis, Rory M.
Siddon, Alexa J.
Zeidan, Amer M.
- License Information
-
More Information
Article History
Accepted: 1 April 2021
First Online: 22 April 2021
Declarations
:
: A.M.Z. received research funding (institutional) from Celgene, Acceleron, Abbvie, Otsuka, Pfizer, Medimmune/AstraZeneca, Boehringer-Ingelheim, Trovagene, Incyte, Takeda, and ADC Therapeutics. A.M.Z had a consultancy with and received honoraria from AbbVie, Otsuka, Pfizer, Celgene, Ariad, Incyte, Agios, Boehringer-Ingelheim, Novartis, Acceleron, Astellas, Daiichi Sankyo, Cardinal Health, Seattle Genetics, BeyondSpring, and Takeda. None of these relationships were related to the development of this manuscript. All other authors report no relevant disclosures/competing interests.
